-
Added BIOCON to watchlistThe company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune.Sales Growth > 10% Profit Margin > 15% Attractive Valuation NIFTY NEXT 50 + 10 indices